Antioxidants in kidney diseases: the impact of bardoxolone methyl.
about
Citral is renoprotective for focal segmental glomerulosclerosis by inhibiting oxidative stress and apoptosis and activating Nrf2 pathway in miceDiabetic nephropathy and antioxidants.Polymorphisms in genes encoding antioxidant enzymes (SOD2, CAT, GPx, TXNRD, SEPP1, SEP15 and SELS) and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study.Rotenone remarkably attenuates oxidative stress, inflammation, and fibrosis in chronic obstructive uropathyDiscontinued in 2013: diabetic drugs.New Insights into the Pathogenesis of Preeclampsia - The Role of Nrf2 Activators and their Potential Therapeutic Impact.Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications.Binding of disordered proteins to a protein hub.Effects of captopril, telmisartan and bardoxolone methyl (CDDO-Me) in ischemia-reperfusion-induced acute kidney injury in rats: an experimental comparative study.Habitual dietary intake of β-carotene, vitamin C, folate, or vitamin E may interact with single nucleotide polymorphisms on brachial-ankle pulse wave velocity in healthy adults.Administration of antioxidants in chronic kidney disease.
P2860
Q28533529-1CB868BB-31A5-46CD-823A-A6DCFCD9D770Q30486658-2027C0F3-E78D-462F-93EA-AF5B7FA612A4Q30656525-01A44242-1F31-42DD-8A44-C47C58B725AFQ34033183-4D7D9A81-E29C-4180-82EA-21401210B856Q34664870-8D0EFBDD-4C66-47DE-9473-53CA78CA0CA6Q37660596-99024D74-ADE2-4445-8891-B1044355922DQ38054089-EDC53EE1-39B6-4CD7-98A3-02EA89E2BAFBQ42041592-0933E1AC-B944-46F7-8DB7-BE5D8B5D98D1Q48111922-6236C139-FF4D-42CA-AB96-0B2E2EA88E9BQ53224400-8C0362ED-B6BB-463E-9B18-923FD50CC611Q53785782-09645796-426F-4010-8B48-D05C3DE9A7DD
P2860
Antioxidants in kidney diseases: the impact of bardoxolone methyl.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Antioxidants in kidney diseases: the impact of bardoxolone methyl.
@ast
Antioxidants in kidney diseases: the impact of bardoxolone methyl.
@en
type
label
Antioxidants in kidney diseases: the impact of bardoxolone methyl.
@ast
Antioxidants in kidney diseases: the impact of bardoxolone methyl.
@en
prefLabel
Antioxidants in kidney diseases: the impact of bardoxolone methyl.
@ast
Antioxidants in kidney diseases: the impact of bardoxolone methyl.
@en
P2860
P356
P1476
Antioxidants in kidney diseases: the impact of bardoxolone methyl.
@en
P2093
Jesus Egido
Jorge Rojas-Rivera
P2860
P304
P356
10.1155/2012/321714
P577
2012-06-04T00:00:00Z